Literature DB >> 19528086

PROMISE: a tool to identify genomic features with a specific biologically interesting pattern of associations with multiple endpoint variables.

Stan Pounds1, Cheng Cheng, Xueyuan Cao, Kristine R Crews, William Plunkett, Varsha Gandhi, Jeffrey Rubnitz, Raul C Ribeiro, James R Downing, Jatinder Lamba.   

Abstract

MOTIVATION: In some applications, prior biological knowledge can be used to define a specific pattern of association of multiple endpoint variables with a genomic variable that is biologically most interesting. However, to our knowledge, there is no statistical procedure designed to detect specific patterns of association with multiple endpoint variables.
RESULTS: Projection onto the most interesting statistical evidence (PROMISE) is proposed as a general procedure to identify genomic variables that exhibit a specific biologically interesting pattern of association with multiple endpoint variables. Biological knowledge of the endpoint variables is used to define a vector that represents the biologically most interesting values for statistics that characterize the associations of the endpoint variables with a genomic variable. A test statistic is defined as the dot-product of the vector of the observed association statistics and the vector of the most interesting values of the association statistics. By definition, this test statistic is proportional to the length of the projection of the observed vector of correlations onto the vector of most interesting associations. Statistical significance is determined via permutation. In simulation studies and an example application, PROMISE shows greater statistical power to identify genes with the interesting pattern of associations than classical multivariate procedures, individual endpoint analyses or listing genes that have the pattern of interest and are significant in more than one individual endpoint analysis. AVAILABILITY: Documented R routines are freely available from www.stjuderesearch.org/depts/biostats and will soon be available as a Bioconductor package from www.bioconductor.org.

Mesh:

Year:  2009        PMID: 19528086      PMCID: PMC2723006          DOI: 10.1093/bioinformatics/btp357

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  11 in total

1.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

2.  A multiple testing procedure to associate gene expression levels with survival.

Authors:  Sin-Ho Jung; Kouros Owzar; Stephen L George
Journal:  Stat Med       Date:  2005-10-30       Impact factor: 2.373

Review 3.  Statistical development and evaluation of microarray gene expression data filters.

Authors:  Stan Pounds; Cheng Cheng
Journal:  J Comput Biol       Date:  2005-05       Impact factor: 1.479

Review 4.  Estimation and control of multiple testing error rates for microarray studies.

Authors:  Stanley B Pounds
Journal:  Brief Bioinform       Date:  2006-03       Impact factor: 11.622

5.  Extensions to gene set enrichment.

Authors:  Zhen Jiang; Robert Gentleman
Journal:  Bioinformatics       Date:  2006-11-24       Impact factor: 6.937

6.  Identification of differentially expressed gene categories in microarray studies using nonparametric multivariate analysis.

Authors:  Dan Nettleton; Justin Recknor; James M Reecy
Journal:  Bioinformatics       Date:  2007-11-27       Impact factor: 6.937

7.  Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia.

Authors:  Kristine R Crews; Varsha Gandhi; Deo Kumar Srivastava; Bassem I Razzouk; Xin Tong; Fred G Behm; William Plunkett; Susana C Raimondi; Ching-Hon Pui; Jeffrey E Rubnitz; Clinton F Stewart; Raul C Ribeiro
Journal:  J Clin Oncol       Date:  2002-10-15       Impact factor: 44.544

8.  Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.

Authors:  Jun J Yang; Cheng Cheng; Wenjian Yang; Deqing Pei; Xueyuan Cao; Yiping Fan; Stanley B Pounds; Geoffrey Neale; Lisa R Treviño; Deborah French; Dario Campana; James R Downing; William E Evans; Ching-Hon Pui; Meenakshi Devidas; W P Bowman; Bruce M Camitta; Cheryl L Willman; Stella M Davies; Michael J Borowitz; William L Carroll; Stephen P Hunger; Mary V Relling
Journal:  JAMA       Date:  2009-01-28       Impact factor: 56.272

9.  Gene expression profiling of pediatric acute myelogenous leukemia.

Authors:  Mary E Ross; Rami Mahfouz; Mihaela Onciu; Hsi-Che Liu; Xiaodong Zhou; Guangchun Song; Sheila A Shurtleff; Stanley Pounds; Cheng Cheng; Jing Ma; Raul C Ribeiro; Jeffrey E Rubnitz; Kevin Girtman; W Kent Williams; Susana C Raimondi; Der-Cherng Liang; Lee-Yung Shih; Ching-Hon Pui; James R Downing
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

10.  The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.

Authors:  I Hubeek; R W Stam; G J Peters; R Broekhuizen; J P P Meijerink; E R van Wering; B E S Gibson; U Creutzig; C M Zwaan; J Cloos; D J Kuik; R Pieters; G J L Kaspers
Journal:  Br J Cancer       Date:  2005-12-12       Impact factor: 7.640

View more
  9 in total

Review 1.  Pharmacogenomics in pediatric leukemia.

Authors:  Steven W Paugh; Gabriele Stocco; William E Evans
Journal:  Curr Opin Pediatr       Date:  2010-12       Impact factor: 2.856

2.  A procedure to statistically evaluate agreement of differential expression for cross-species genomics.

Authors:  Stan Pounds; Cuilan Lani Gao; Robert A Johnson; Karen D Wright; Helen Poppleton; David Finkelstein; Sarah E S Leary; Richard J Gilbertson
Journal:  Bioinformatics       Date:  2011-06-22       Impact factor: 6.937

3.  Integrated analysis of pharmacologic, clinical and SNP microarray data using Projection Onto the Most Interesting Statistical Evidence with Adaptive Permutation Testing.

Authors:  Stan Pounds; Xueyuan Cao; Cheng Cheng; Jun J Yang; Dario Campana; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  Int J Data Min Bioinform       Date:  2011       Impact factor: 0.667

4.  Genetics of pleiotropic effects of dexamethasone.

Authors:  Laura B Ramsey; Stan Pounds; Cheng Cheng; Xueyuan Cao; Wenjian Yang; Colton Smith; Seth E Karol; Chengcheng Liu; John C Panetta; Hiroto Inaba; Jeffrey E Rubnitz; Monika L Metzger; Raul C Ribeiro; John T Sandlund; Sima Jeha; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  Pharmacogenet Genomics       Date:  2017-08       Impact factor: 2.089

5.  Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes.

Authors:  Jatinder K Lamba; Kristine R Crews; Stanley B Pounds; Xueyuan Cao; Varsha Gandhi; William Plunkett; Bassem I Razzouk; Vishal Lamba; Sharyn D Baker; Susana C Raimondi; Dario Campana; Ching-Hon Pui; James R Downing; Jeffrey E Rubnitz; Raul C Ribeiro
Journal:  Pharmacogenomics       Date:  2011-03       Impact factor: 2.533

6.  Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.

Authors:  Amit K Mitra; Kristine R Crews; Stanley Pounds; Xueyuan Cao; Tanya Feldberg; Yogita Ghodke; Varsha Gandhi; William Plunkett; M Eileen Dolan; Christine Hartford; Susana Raimondi; Dario Campana; James Downing; Jeffrey E Rubnitz; Raul C Ribeiro; Jatinder K Lamba
Journal:  J Pharmacol Exp Ther       Date:  2011-06-28       Impact factor: 4.030

7.  Clinical significance of in vivo cytarabine-induced gene expression signature in AML.

Authors:  Jatinder K Lamba; Stanley Pounds; Xueyuan Cao; Kristine R Crews; Christopher R Cogle; Neha Bhise; Susana C Raimondi; James R Downing; Sharyn D Baker; Raul C Ribeiro; Jeffrey E Rubnitz
Journal:  Leuk Lymphoma       Date:  2015-10-16

8.  SIDEKICK: Genomic data driven analysis and decision-making framework.

Authors:  Mark S Doderer; Kihoon Yoon; Kay A Robbins
Journal:  BMC Bioinformatics       Date:  2010-12-30       Impact factor: 3.169

9.  CC-PROMISE effectively integrates two forms of molecular data with multiple biologically related endpoints.

Authors:  Xueyuan Cao; Kristine R Crews; James Downing; Jatinder Lamba; Stanley B Pounds
Journal:  BMC Bioinformatics       Date:  2016-10-06       Impact factor: 3.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.